Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botanical Tincture for IBS-C
NCT03923322Phase 2Withdrawn
- Sponsor
- Stamford Hospital
- Start
- Jan 2025
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irritable bowel syndrome (IBS) (2 arms), sponsored by Stamford Hospital. Primary endpoints: Number of subjects recruited at 2 years, Proportion of subjects who complete the study at 12 weeks and 1 more. Planned start Jan 2025; status: withdrawn.
02
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT03923322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03923322.